Rank | Gene Set | Z-score |
---|---|---|
1 | basement membrane organization (GO:0071711) | 3.98142035 |
2 | Golgi transport vesicle coating (GO:0048200) | 3.94623306 |
3 | COPI coating of Golgi vesicle (GO:0048205) | 3.94623306 |
4 | barbed-end actin filament capping (GO:0051016) | 3.92419356 |
5 | skin morphogenesis (GO:0043589) | 3.86108533 |
6 | positive regulation of histone deacetylation (GO:0031065) | 3.74598534 |
7 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.62316891 |
8 | peptidyl-lysine dimethylation (GO:0018027) | 3.62143763 |
9 | regulation of cholesterol homeostasis (GO:2000188) | 3.56698511 |
10 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.56284854 |
11 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.54250034 |
12 | positive regulation of nuclease activity (GO:0032075) | 3.49901132 |
13 | hemidesmosome assembly (GO:0031581) | 3.49540290 |
14 | negative regulation of cell size (GO:0045792) | 3.49106470 |
15 | alpha-linolenic acid metabolic process (GO:0036109) | 3.47206303 |
16 | semaphorin-plexin signaling pathway (GO:0071526) | 3.44461513 |
17 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.39116172 |
18 | apoptotic cell clearance (GO:0043277) | 3.38143910 |
19 | protein localization to endosome (GO:0036010) | 3.33519716 |
20 | regulation of extracellular matrix disassembly (GO:0010715) | 3.29691655 |
21 | response to laminar fluid shear stress (GO:0034616) | 3.25244681 |
22 | regulation of nuclease activity (GO:0032069) | 3.12027017 |
23 | maternal placenta development (GO:0001893) | 3.09930651 |
24 | low-density lipoprotein particle clearance (GO:0034383) | 3.09691546 |
25 | peptidyl-proline hydroxylation (GO:0019511) | 3.09555504 |
26 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.09501306 |
27 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 3.09442891 |
28 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.08817298 |
29 | mannose metabolic process (GO:0006013) | 3.05965470 |
30 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.05165270 |
31 | lysine metabolic process (GO:0006553) | 3.03825042 |
32 | lysine catabolic process (GO:0006554) | 3.03825042 |
33 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.03719874 |
34 | endothelial cell chemotaxis (GO:0035767) | 3.01655144 |
35 | endodermal cell differentiation (GO:0035987) | 2.97028221 |
36 | pinocytosis (GO:0006907) | 2.96628902 |
37 | adherens junction assembly (GO:0034333) | 2.95878478 |
38 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.95527425 |
39 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.93794832 |
40 | cellular response to unfolded protein (GO:0034620) | 2.91644872 |
41 | regulation of translational fidelity (GO:0006450) | 2.90685246 |
42 | negative regulation of fatty acid transport (GO:2000192) | 2.90476938 |
43 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.90024032 |
44 | negative regulation of fibrinolysis (GO:0051918) | 2.89699839 |
45 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.89252050 |
46 | negative regulation of lipid transport (GO:0032369) | 2.87389255 |
47 | proline biosynthetic process (GO:0006561) | 2.86282739 |
48 | ER-nucleus signaling pathway (GO:0006984) | 2.86249116 |
49 | 4-hydroxyproline metabolic process (GO:0019471) | 2.86127261 |
50 | macroautophagy (GO:0016236) | 2.85904912 |
51 | positive regulation of receptor recycling (GO:0001921) | 2.85624977 |
52 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.83315098 |
53 | regulation of translational termination (GO:0006449) | 2.82389291 |
54 | regulation of hippo signaling (GO:0035330) | 2.80705010 |
55 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.79140748 |
56 | protein maturation by protein folding (GO:0022417) | 2.78299470 |
57 | NLS-bearing protein import into nucleus (GO:0006607) | 2.78069017 |
58 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.74968026 |
59 | negative regulation of sterol transport (GO:0032372) | 2.74474943 |
60 | negative regulation of cholesterol transport (GO:0032375) | 2.74474943 |
61 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.74421915 |
62 | receptor catabolic process (GO:0032801) | 2.73969132 |
63 | pre-miRNA processing (GO:0031054) | 2.72568510 |
64 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.72516325 |
65 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.72017403 |
66 | embryo implantation (GO:0007566) | 2.69532963 |
67 | regulation of early endosome to late endosome transport (GO:2000641) | 2.69430124 |
68 | stress fiber assembly (GO:0043149) | 2.68666053 |
69 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.67955692 |
70 | hippo signaling (GO:0035329) | 2.67525487 |
71 | membrane protein ectodomain proteolysis (GO:0006509) | 2.66916837 |
72 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.66887646 |
73 | cellular response to topologically incorrect protein (GO:0035967) | 2.66521144 |
74 | cell adhesion mediated by integrin (GO:0033627) | 2.66492179 |
75 | desmosome organization (GO:0002934) | 2.65111919 |
76 | positive regulation of extracellular matrix organization (GO:1903055) | 2.64753514 |
77 | amyloid precursor protein catabolic process (GO:0042987) | 2.64423838 |
78 | apoptotic process involved in morphogenesis (GO:0060561) | 2.63968365 |
79 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.63563350 |
80 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.63349426 |
81 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.61762917 |
82 | hyaluronan catabolic process (GO:0030214) | 2.61620592 |
83 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.60610499 |
84 | heterochromatin organization (GO:0070828) | 2.59186820 |
85 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.58946561 |
86 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.58636927 |
87 | regulation of cholesterol storage (GO:0010885) | 2.57733637 |
88 | pentose-phosphate shunt (GO:0006098) | 2.56798688 |
89 | glucose 6-phosphate metabolic process (GO:0051156) | 2.54782850 |
90 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.54596845 |
91 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.54596845 |
92 | cell-substrate junction assembly (GO:0007044) | 2.52950769 |
93 | regulation of extracellular matrix organization (GO:1903053) | 2.52885923 |
94 | growth hormone receptor signaling pathway (GO:0060396) | 2.52196498 |
95 | type B pancreatic cell proliferation (GO:0044342) | 2.52094516 |
96 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.51975071 |
97 | activation of Rac GTPase activity (GO:0032863) | 2.51579186 |
98 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.51410412 |
99 | embryonic foregut morphogenesis (GO:0048617) | 2.50717227 |
100 | sulfur amino acid catabolic process (GO:0000098) | 2.50375500 |
101 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.49539911 |
102 | glial cell proliferation (GO:0014009) | 2.49492132 |
103 | UV protection (GO:0009650) | 2.49466620 |
104 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.49322007 |
105 | focal adhesion assembly (GO:0048041) | 2.49095865 |
106 | cell-substrate adherens junction assembly (GO:0007045) | 2.49095865 |
107 | maintenance of protein localization in organelle (GO:0072595) | 2.48111754 |
108 | protein retention in ER lumen (GO:0006621) | 2.47605179 |
109 | retrograde transport, endosome to Golgi (GO:0042147) | 2.47252601 |
110 | urea cycle (GO:0000050) | 2.47090837 |
111 | urea metabolic process (GO:0019627) | 2.47090837 |
112 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.46612054 |
113 | protein heterotrimerization (GO:0070208) | 2.43467931 |
114 | atrioventricular valve morphogenesis (GO:0003181) | 2.42233855 |
115 | glycine metabolic process (GO:0006544) | 2.41414667 |
116 | 2-oxoglutarate metabolic process (GO:0006103) | 2.40755854 |
117 | positive regulation of protein deacetylation (GO:0090312) | 2.40690616 |
118 | cortical actin cytoskeleton organization (GO:0030866) | 2.40348641 |
119 | collagen metabolic process (GO:0032963) | 2.39892053 |
120 | adhesion of symbiont to host (GO:0044406) | 2.39484061 |
121 | glucose catabolic process (GO:0006007) | 2.39338079 |
122 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.39008147 |
123 | extracellular matrix disassembly (GO:0022617) | 2.38757725 |
124 | response to endoplasmic reticulum stress (GO:0034976) | 2.38483987 |
125 | cellular copper ion homeostasis (GO:0006878) | 2.38410678 |
126 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.38348915 |
127 | actin filament depolymerization (GO:0030042) | 2.37753453 |
128 | cell-cell junction maintenance (GO:0045217) | 2.37753188 |
129 | vesicle coating (GO:0006901) | 2.37738839 |
130 | fatty acid homeostasis (GO:0055089) | 2.37169689 |
131 | collagen fibril organization (GO:0030199) | 2.36506006 |
132 | regulation of polysaccharide biosynthetic process (GO:0032885) | 2.36231444 |
133 | fibril organization (GO:0097435) | 2.35838079 |
134 | extracellular fibril organization (GO:0043206) | 2.35781322 |
135 | protein targeting to plasma membrane (GO:0072661) | 2.35722966 |
136 | sexual reproduction (GO:0019953) | 2.35706828 |
137 | modulation by symbiont of host cellular process (GO:0044068) | 2.35369518 |
138 | germ cell migration (GO:0008354) | 2.35248208 |
139 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.32919290 |
140 | embryonic process involved in female pregnancy (GO:0060136) | 2.32792627 |
141 | mRNA stabilization (GO:0048255) | 2.32606058 |
142 | RNA stabilization (GO:0043489) | 2.32606058 |
143 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.32579075 |
144 | protein carboxylation (GO:0018214) | 2.32579075 |
145 | epithelial cell-cell adhesion (GO:0090136) | 2.31418450 |
146 | sodium ion export (GO:0071436) | 2.31120164 |
147 | substrate-dependent cell migration (GO:0006929) | 2.31023525 |
148 | establishment of apical/basal cell polarity (GO:0035089) | 2.27598729 |
149 | cellular response to epidermal growth factor stimulus (GO:0071364) | 2.25585457 |
150 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.25236941 |
151 | regulation of chromatin binding (GO:0035561) | 2.25028240 |
152 | tricarboxylic acid metabolic process (GO:0072350) | 2.23281149 |
153 | NADPH regeneration (GO:0006740) | 2.22342293 |
154 | blood vessel endothelial cell migration (GO:0043534) | 2.21840335 |
155 | establishment of nucleus localization (GO:0040023) | 2.21690690 |
156 | midgut development (GO:0007494) | 2.21545907 |
157 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.20993362 |
158 | protein hydroxylation (GO:0018126) | 2.20897801 |
159 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.19488545 |
160 | corticosteroid receptor signaling pathway (GO:0031958) | 2.19127776 |
161 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.18870410 |
162 | positive regulation of glycogen metabolic process (GO:0070875) | 2.18458103 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.78299601 |
2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.55062939 |
3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.32740136 |
4 | MYC_22102868_ChIP-Seq_BL_Human | 2.85761485 |
5 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.62852749 |
6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.61167075 |
7 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.60640332 |
8 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.52037735 |
9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.33073900 |
10 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.30988644 |
11 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.24219078 |
12 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.22942576 |
13 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.22179335 |
14 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.20871280 |
15 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.19452261 |
16 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.17902695 |
17 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.15660424 |
18 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.12976181 |
19 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.05389098 |
20 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.95301199 |
21 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.93442584 |
22 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.93064837 |
23 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.92503331 |
24 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.87223074 |
25 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.84193643 |
26 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.82222791 |
27 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.80863516 |
28 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.77204508 |
29 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.76503158 |
30 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.69893440 |
31 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.68361926 |
32 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.68267876 |
33 | KDM2B_26808549_Chip-Seq_K562_Human | 1.66772621 |
34 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.61990841 |
35 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.60246187 |
36 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.57075411 |
37 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.56020965 |
38 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.55204332 |
39 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.52340455 |
40 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.50540708 |
41 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.50124855 |
42 | ATF3_27146783_Chip-Seq_COLON_Human | 1.49580758 |
43 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.48690619 |
44 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.47832922 |
45 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.47241952 |
46 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.45572651 |
47 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.44018216 |
48 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.41789190 |
49 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.41065159 |
50 | MAF_26560356_Chip-Seq_TH1_Human | 1.39701478 |
51 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.38427959 |
52 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.38416116 |
53 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.37831276 |
54 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.37769483 |
55 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.37347972 |
56 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.37008663 |
57 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.36202317 |
58 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.35621529 |
59 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.34136412 |
60 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.33149847 |
61 | UTX_26944678_Chip-Seq_JUKART_Human | 1.32856363 |
62 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.31113101 |
63 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.30891577 |
64 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.30737890 |
65 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.30572630 |
66 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.29989841 |
67 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.29349599 |
68 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.26973654 |
69 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.26376996 |
70 | * CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.25054798 |
71 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.24080904 |
72 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.21920137 |
73 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.21777779 |
74 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.20493009 |
75 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.20258232 |
76 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.17216908 |
77 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.16515803 |
78 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.16291022 |
79 | MAF_26560356_Chip-Seq_TH2_Human | 1.16207998 |
80 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.16142128 |
81 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.16094569 |
82 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.15938067 |
83 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15673051 |
84 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.15591880 |
85 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.15344995 |
86 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.15060925 |
87 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.14456628 |
88 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.13027263 |
89 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.12490188 |
90 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.12092381 |
91 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.12090639 |
92 | GATA1_19941826_ChIP-Seq_K562_Human | 1.10784663 |
93 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.10202718 |
94 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.09714208 |
95 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.09707658 |
96 | P68_20966046_ChIP-Seq_HELA_Human | 1.09509888 |
97 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.09422406 |
98 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.08861812 |
99 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.08591941 |
100 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.08540294 |
101 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.08457397 |
102 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.07007454 |
103 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.06864024 |
104 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.06516428 |
105 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.06009372 |
106 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05725903 |
107 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.05139152 |
108 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.04656210 |
109 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.03765849 |
110 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.03600540 |
111 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.03436265 |
112 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.02678645 |
113 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.02369666 |
114 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.01346637 |
115 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.00699786 |
116 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.99877390 |
117 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.99767723 |
118 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.99141929 |
119 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.99090798 |
120 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.98659953 |
121 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.98659953 |
122 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.98630007 |
123 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.98233488 |
124 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.98198040 |
125 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.97960578 |
126 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.96161165 |
127 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.95950511 |
128 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.95287103 |
129 | SPI1_23127762_ChIP-Seq_K562_Human | 0.94860654 |
130 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.94197532 |
131 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.92932383 |
132 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.90628840 |
133 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.89831621 |
134 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.89497823 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003705_abnormal_hypodermis_morpholog | 5.07517281 |
2 | MP0010234_abnormal_vibrissa_follicle | 3.35418766 |
3 | MP0002139_abnormal_hepatobiliary_system | 3.32279693 |
4 | MP0003300_gastrointestinal_ulcer | 3.19919500 |
5 | MP0005360_urolithiasis | 2.79326555 |
6 | MP0010352_gastrointestinal_tract_polyps | 2.75898953 |
7 | MP0008438_abnormal_cutaneous_collagen | 2.72824988 |
8 | MP0005257_abnormal_intraocular_pressure | 2.57643361 |
9 | MP0005076_abnormal_cell_differentiation | 2.54209971 |
10 | MP0005451_abnormal_body_composition | 2.36679902 |
11 | MP0008260_abnormal_autophagy | 2.35893695 |
12 | MP0009840_abnormal_foam_cell | 2.26544601 |
13 | MP0003566_abnormal_cell_adhesion | 2.21230467 |
14 | MP0003283_abnormal_digestive_organ | 2.15614037 |
15 | MP0008961_abnormal_basal_metabolism | 2.11851628 |
16 | MP0003252_abnormal_bile_duct | 2.11451869 |
17 | MP0009384_cardiac_valve_regurgitation | 2.05602669 |
18 | MP0003303_peritoneal_inflammation | 2.02100271 |
19 | MP0005365_abnormal_bile_salt | 2.00639895 |
20 | MP0002877_abnormal_melanocyte_morpholog | 1.97506087 |
21 | MP0000537_abnormal_urethra_morphology | 1.96533938 |
22 | MP0006054_spinal_hemorrhage | 1.89420906 |
23 | MP0005085_abnormal_gallbladder_physiolo | 1.79915244 |
24 | MP0010329_abnormal_lipoprotein_level | 1.77716051 |
25 | MP0009278_abnormal_bone_marrow | 1.74431408 |
26 | MP0010307_abnormal_tumor_latency | 1.73575310 |
27 | MP0005409_darkened_coat_color | 1.69090823 |
28 | MP0004185_abnormal_adipocyte_glucose | 1.65511863 |
29 | MP0000751_myopathy | 1.64794079 |
30 | MP0005623_abnormal_meninges_morphology | 1.63875253 |
31 | MP0004130_abnormal_muscle_cell | 1.61744090 |
32 | MP0003191_abnormal_cellular_cholesterol | 1.60960608 |
33 | MP0000858_altered_metastatic_potential | 1.60191662 |
34 | MP0001849_ear_inflammation | 1.54965762 |
35 | MP0000569_abnormal_digit_pigmentation | 1.52833268 |
36 | MP0005503_abnormal_tendon_morphology | 1.50908063 |
37 | MP0003436_decreased_susceptibility_to | 1.49567549 |
38 | MP0000733_abnormal_muscle_development | 1.46969175 |
39 | MP0003091_abnormal_cell_migration | 1.45035301 |
40 | MP0005083_abnormal_biliary_tract | 1.45002200 |
41 | MP0000767_abnormal_smooth_muscle | 1.43733294 |
42 | MP0009780_abnormal_chondrocyte_physiolo | 1.39557791 |
43 | MP0003045_fibrosis | 1.36705841 |
44 | MP0004858_abnormal_nervous_system | 1.36396455 |
45 | MP0004264_abnormal_extraembryonic_tissu | 1.36193985 |
46 | MP0001666_abnormal_nutrient_absorption | 1.34540420 |
47 | MP0003172_abnormal_lysosome_physiology | 1.34409636 |
48 | MP0005666_abnormal_adipose_tissue | 1.33657018 |
49 | MP0001958_emphysema | 1.30014819 |
50 | MP0000609_abnormal_liver_physiology | 1.29633441 |
51 | MP0005023_abnormal_wound_healing | 1.28633685 |
52 | MP0005275_abnormal_skin_tensile | 1.28255865 |
53 | MP0000003_abnormal_adipose_tissue | 1.21970564 |
54 | MP0005375_adipose_tissue_phenotype | 1.21352564 |
55 | MP0009053_abnormal_anal_canal | 1.20374224 |
56 | MP0004272_abnormal_basement_membrane | 1.20274649 |
57 | MP0005058_abnormal_lysosome_morphology | 1.20210053 |
58 | MP0001243_abnormal_dermal_layer | 1.17100181 |
59 | MP0003115_abnormal_respiratory_system | 1.15876330 |
60 | MP0010368_abnormal_lymphatic_system | 1.12598313 |
61 | MP0010030_abnormal_orbit_morphology | 1.11595975 |
62 | MP0004197_abnormal_fetal_growth/weight/ | 1.11155378 |
63 | MP0001915_intracranial_hemorrhage | 1.10634353 |
64 | MP0002796_impaired_skin_barrier | 1.10492416 |
65 | MP0005167_abnormal_blood-brain_barrier | 1.04548400 |
66 | MP0002653_abnormal_ependyma_morphology | 1.03417119 |
67 | MP0002896_abnormal_bone_mineralization | 1.02514595 |
68 | MP0000013_abnormal_adipose_tissue | 1.02498477 |
69 | MP0005187_abnormal_penis_morphology | 1.01840230 |
70 | MP0002086_abnormal_extraembryonic_tissu | 1.01513267 |
71 | MP0002909_abnormal_adrenal_gland | 1.01178154 |
72 | MP0005501_abnormal_skin_physiology | 1.00952487 |
73 | MP0002138_abnormal_hepatobiliary_system | 1.00903100 |
74 | MP0002998_abnormal_bone_remodeling | 1.00739696 |
75 | MP0000678_abnormal_parathyroid_gland | 0.98836226 |
76 | MP0001730_embryonic_growth_arrest | 0.97032447 |
77 | MP0000604_amyloidosis | 0.96200689 |
78 | MP0005670_abnormal_white_adipose | 0.94777780 |
79 | MP0005508_abnormal_skeleton_morphology | 0.94110418 |
80 | MP0001348_abnormal_lacrimal_gland | 0.93824981 |
81 | MP0001533_abnormal_skeleton_physiology | 0.92867429 |
82 | MP0003183_abnormal_peptide_metabolism | 0.92290316 |
83 | MP0005621_abnormal_cell_physiology | 0.91999087 |
84 | MP0004233_abnormal_muscle_weight | 0.91987958 |
85 | MP0002933_joint_inflammation | 0.91871924 |
86 | MP0001542_abnormal_bone_strength | 0.91676955 |
87 | MP0009672_abnormal_birth_weight | 0.91476211 |
88 | MP0003634_abnormal_glial_cell | 0.91256981 |
89 | MP0003279_aneurysm | 0.91073861 |
90 | MP0000598_abnormal_liver_morphology | 0.89539690 |
91 | MP0004947_skin_inflammation | 0.88662679 |
92 | MP0002118_abnormal_lipid_homeostasis | 0.88459539 |
93 | MP0008875_abnormal_xenobiotic_pharmacok | 0.88458001 |
94 | MP0004808_abnormal_hematopoietic_stem | 0.85796445 |
95 | MP0002084_abnormal_developmental_patter | 0.84363639 |
96 | MP0003453_abnormal_keratinocyte_physiol | 0.83551479 |
97 | MP0002168_other_aberrant_phenotype | 0.83060714 |
98 | MP0009703_decreased_birth_body | 0.81742631 |
99 | MP0002089_abnormal_postnatal_growth/wei | 0.81545268 |
100 | MP0000428_abnormal_craniofacial_morphol | 0.81146768 |
101 | MP0003075_altered_response_to | 0.79013112 |
102 | MP0001216_abnormal_epidermal_layer | 0.78936625 |
103 | MP0005390_skeleton_phenotype | 0.78916344 |
104 | MP0009931_abnormal_skin_appearance | 0.77309110 |
105 | MP0002088_abnormal_embryonic_growth/wei | 0.76980538 |
106 | MP0002928_abnormal_bile_duct | 0.76504540 |
107 | MP0003984_embryonic_growth_retardation | 0.75657427 |
108 | MP0002254_reproductive_system_inflammat | 0.75554240 |
109 | MP0002295_abnormal_pulmonary_circulatio | 0.75351571 |
110 | MP0004510_myositis | 0.74774711 |
111 | MP0002092_abnormal_eye_morphology | 0.73818217 |
112 | MP0009643_abnormal_urine_homeostasis | 0.73640743 |
113 | MP0000750_abnormal_muscle_regeneration | 0.73604280 |
114 | MP0003448_altered_tumor_morphology | 0.73224425 |
115 | MP0006082_CNS_inflammation | 0.72931498 |
116 | MP0001614_abnormal_blood_vessel | 0.72834194 |
117 | MP0002166_altered_tumor_susceptibility | 0.72657887 |
118 | MP0002697_abnormal_eye_size | 0.72569135 |
119 | MP0002080_prenatal_lethality | 0.72357510 |
120 | MP0000534_abnormal_ureter_morphology | 0.72149658 |
121 | MP0000681_abnormal_thyroid_gland | 0.72085255 |
122 | MP0005319_abnormal_enzyme/_coenzyme | 0.71785061 |
123 | MP0000759_abnormal_skeletal_muscle | 0.71739757 |
124 | MP0001672_abnormal_embryogenesis/_devel | 0.71466718 |
125 | MP0005380_embryogenesis_phenotype | 0.71466718 |
126 | MP0002925_abnormal_cardiovascular_devel | 0.70313669 |
127 | MP0000371_diluted_coat_color | 0.70213502 |
128 | MP0005332_abnormal_amino_acid | 0.69834523 |
129 | MP0003795_abnormal_bone_structure | 0.69549257 |
130 | MP0000747_muscle_weakness | 0.69524555 |
131 | MP0001661_extended_life_span | 0.69422864 |
132 | MP0000462_abnormal_digestive_system | 0.68920306 |
133 | MP0003868_abnormal_feces_composition | 0.68558434 |
134 | MP0005464_abnormal_platelet_physiology | 0.68290150 |
135 | MP0008770_decreased_survivor_rate | 0.68067230 |
136 | MP0003329_amyloid_beta_deposits | 0.68026663 |
137 | MP0003119_abnormal_digestive_system | 0.67731572 |
138 | MP0002060_abnormal_skin_morphology | 0.67205273 |
139 | MP0005164_abnormal_response_to | 0.67032384 |
140 | MP0005220_abnormal_exocrine_pancreas | 0.66999062 |
141 | MP0000467_abnormal_esophagus_morphology | 0.65320573 |
142 | MP0001697_abnormal_embryo_size | 0.65230060 |
143 | MP0010771_integument_phenotype | 0.64459257 |
144 | MP0000762_abnormal_tongue_morphology | 0.63758513 |
145 | MP0002249_abnormal_larynx_morphology | 0.62733043 |
146 | MP0000249_abnormal_blood_vessel | 0.62433780 |
147 | MP0000579_abnormal_nail_morphology | 0.61604296 |
148 | MP0005330_cardiomyopathy | 0.60251278 |
149 | MP0010630_abnormal_cardiac_muscle | 0.59537704 |
150 | MP0005384_cellular_phenotype | 0.59524414 |
151 | MP0003828_pulmonary_edema | 0.59495390 |
152 | MP0006138_congestive_heart_failure | 0.59478747 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Cerebral aneurysm (HP:0004944) | 4.03993488 |
2 | Vertebral compression fractures (HP:0002953) | 3.54427217 |
3 | Atrophic scars (HP:0001075) | 3.32420892 |
4 | Protrusio acetabuli (HP:0003179) | 3.25650749 |
5 | Hyperacusis (HP:0010780) | 3.23802728 |
6 | Deep venous thrombosis (HP:0002625) | 3.22409152 |
7 | Abnormality of the lower motor neuron (HP:0002366) | 3.12211512 |
8 | Shallow orbits (HP:0000586) | 3.09037438 |
9 | Hand muscle atrophy (HP:0009130) | 3.08065138 |
10 | Upper limb amyotrophy (HP:0009129) | 3.04233706 |
11 | Distal upper limb amyotrophy (HP:0007149) | 3.04233706 |
12 | Broad face (HP:0000283) | 2.96143292 |
13 | Fragile skin (HP:0001030) | 2.95745992 |
14 | Dysostosis multiplex (HP:0000943) | 2.92929640 |
15 | Vascular tortuosity (HP:0004948) | 2.81179184 |
16 | Arterial tortuosity (HP:0005116) | 2.78903580 |
17 | Spastic diplegia (HP:0001264) | 2.75197301 |
18 | Wormian bones (HP:0002645) | 2.68618669 |
19 | Short nail (HP:0001799) | 2.67076383 |
20 | Biconcave vertebral bodies (HP:0004586) | 2.64783291 |
21 | Subacute progressive viral hepatitis (HP:0006572) | 2.62992792 |
22 | Abnormality of dentin (HP:0010299) | 2.61412076 |
23 | Mitral valve prolapse (HP:0001634) | 2.58158718 |
24 | Aneurysm (HP:0002617) | 2.57659460 |
25 | Enlarged penis (HP:0000040) | 2.54523759 |
26 | Ankle contracture (HP:0006466) | 2.54333827 |
27 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.53445644 |
28 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.53445644 |
29 | Abnormality of glycolipid metabolism (HP:0010969) | 2.53445644 |
30 | Premature rupture of membranes (HP:0001788) | 2.53354229 |
31 | Renovascular hypertension (HP:0100817) | 2.48686479 |
32 | Bowel diverticulosis (HP:0005222) | 2.47814490 |
33 | Bladder diverticulum (HP:0000015) | 2.45078868 |
34 | Mitral regurgitation (HP:0001653) | 2.44526715 |
35 | J-shaped sella turcica (HP:0002680) | 2.44290010 |
36 | Aortic aneurysm (HP:0004942) | 2.43159839 |
37 | Elfin facies (HP:0004428) | 2.42837657 |
38 | Spinal rigidity (HP:0003306) | 2.42317947 |
39 | Insomnia (HP:0100785) | 2.40528314 |
40 | Flat acetabular roof (HP:0003180) | 2.37551206 |
41 | Joint stiffness (HP:0001387) | 2.37488357 |
42 | Abnormality of the Achilles tendon (HP:0005109) | 2.35529776 |
43 | Ulnar bowing (HP:0003031) | 2.33388557 |
44 | Distal lower limb amyotrophy (HP:0008944) | 2.32137996 |
45 | Macroorchidism (HP:0000053) | 2.29828399 |
46 | Lymphangioma (HP:0100764) | 2.29724292 |
47 | Achilles tendon contracture (HP:0001771) | 2.28447640 |
48 | Turricephaly (HP:0000262) | 2.28347085 |
49 | Back pain (HP:0003418) | 2.24586205 |
50 | Long toe (HP:0010511) | 2.22050152 |
51 | Dilatation of the ascending aorta (HP:0005111) | 2.21077590 |
52 | Neurofibrillary tangles (HP:0002185) | 2.19397164 |
53 | Hemorrhage of the eye (HP:0011885) | 2.17332313 |
54 | Pseudobulbar signs (HP:0002200) | 2.16941086 |
55 | Soft skin (HP:0000977) | 2.14546411 |
56 | Cerebral inclusion bodies (HP:0100314) | 2.13961882 |
57 | Renal duplication (HP:0000075) | 2.13421181 |
58 | Xanthomatosis (HP:0000991) | 2.12984866 |
59 | Natal tooth (HP:0000695) | 2.09651906 |
60 | Increased density of long bones (HP:0006392) | 2.07753064 |
61 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.06344310 |
62 | Obstructive sleep apnea (HP:0002870) | 2.05084687 |
63 | Distal lower limb muscle weakness (HP:0009053) | 2.03959056 |
64 | Nuclear cataract (HP:0100018) | 2.03773426 |
65 | Heterotopia (HP:0002282) | 2.02593049 |
66 | Hematochezia (HP:0002573) | 2.01662444 |
67 | Joint laxity (HP:0001388) | 2.01354461 |
68 | Cervical subluxation (HP:0003308) | 2.00860044 |
69 | Striae distensae (HP:0001065) | 2.00024201 |
70 | Hallux valgus (HP:0001822) | 1.99255896 |
71 | Aortic dissection (HP:0002647) | 1.96990034 |
72 | Increased variability in muscle fiber diameter (HP:0003557) | 1.96750410 |
73 | Interstitial pulmonary disease (HP:0006530) | 1.96424202 |
74 | Elbow flexion contracture (HP:0002987) | 1.96089678 |
75 | Mitral stenosis (HP:0001718) | 1.95582365 |
76 | Abnormality of the acetabulum (HP:0003170) | 1.95231801 |
77 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.95136954 |
78 | Deviation of the hallux (HP:0010051) | 1.95115972 |
79 | Coxa vara (HP:0002812) | 1.94081800 |
80 | Genu recurvatum (HP:0002816) | 1.93929869 |
81 | Rectal prolapse (HP:0002035) | 1.93154043 |
82 | Thin bony cortex (HP:0002753) | 1.92732573 |
83 | Complement deficiency (HP:0004431) | 1.92314863 |
84 | Broad metatarsal (HP:0001783) | 1.92000442 |
85 | Peritonitis (HP:0002586) | 1.91067999 |
86 | Neonatal short-limb short stature (HP:0008921) | 1.90329425 |
87 | Overriding aorta (HP:0002623) | 1.90104446 |
88 | Myocardial infarction (HP:0001658) | 1.89028086 |
89 | Abnormality of the astrocytes (HP:0100707) | 1.88663492 |
90 | Astrocytoma (HP:0009592) | 1.88663492 |
91 | Resting tremor (HP:0002322) | 1.86459218 |
92 | Spondylolisthesis (HP:0003302) | 1.86287092 |
93 | Abnormal delivery (HP:0001787) | 1.85956445 |
94 | Aortic regurgitation (HP:0001659) | 1.85435459 |
95 | Increased CSF protein (HP:0002922) | 1.85423230 |
96 | Hyperextensible skin (HP:0000974) | 1.85225258 |
97 | Long palpebral fissure (HP:0000637) | 1.84114535 |
98 | Stridor (HP:0010307) | 1.83843657 |
99 | Radial bowing (HP:0002986) | 1.81003132 |
100 | Loss of speech (HP:0002371) | 1.80735323 |
101 | Bowing of the arm (HP:0006488) | 1.79398775 |
102 | Bowed forearm bones (HP:0003956) | 1.79398775 |
103 | Advanced eruption of teeth (HP:0006288) | 1.79393970 |
104 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.78170729 |
105 | Abnormal ossification of hand bones (HP:0005921) | 1.78109334 |
106 | Abnormality of carpal bone ossification (HP:0006257) | 1.77320290 |
107 | Fibroma (HP:0010614) | 1.76543972 |
108 | Buphthalmos (HP:0000557) | 1.75690016 |
109 | Intrahepatic cholestasis (HP:0001406) | 1.75580433 |
110 | Ovoid vertebral bodies (HP:0003300) | 1.73661563 |
111 | Asymmetric septal hypertrophy (HP:0001670) | 1.73061978 |
112 | High pitched voice (HP:0001620) | 1.72028357 |
113 | Follicular hyperkeratosis (HP:0007502) | 1.71555623 |
114 | Supranuclear gaze palsy (HP:0000605) | 1.71469737 |
115 | Ankyloglossia (HP:0010296) | 1.71446154 |
116 | Generalized amyotrophy (HP:0003700) | 1.71370059 |
117 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.71159105 |
118 | Mucopolysacchariduria (HP:0008155) | 1.71159105 |
119 | Abnormality of the thoracic spine (HP:0100711) | 1.69606980 |
120 | Flat cornea (HP:0007720) | 1.69365311 |
121 | Abnormality of oral frenula (HP:0000190) | 1.68358802 |
122 | Disproportionate tall stature (HP:0001519) | 1.68108206 |
123 | Fibrous tissue neoplasm (HP:0012316) | 1.67677076 |
124 | Ependymoma (HP:0002888) | 1.67457326 |
125 | Exostoses (HP:0100777) | 1.67113492 |
126 | Abnormality of the common coagulation pathway (HP:0010990) | 1.66149444 |
127 | Axonal loss (HP:0003447) | 1.65154765 |
128 | Cortical dysplasia (HP:0002539) | 1.64941234 |
129 | * Pointed chin (HP:0000307) | 1.64031587 |
130 | Premature skin wrinkling (HP:0100678) | 1.63910471 |
131 | Amyloidosis (HP:0011034) | 1.63518885 |
132 | Global brain atrophy (HP:0002283) | 1.63517726 |
133 | Difficulty climbing stairs (HP:0003551) | 1.63433197 |
134 | Hepatocellular carcinoma (HP:0001402) | 1.62720788 |
135 | Metaphyseal cupping (HP:0003021) | 1.62402517 |
136 | Polygenic inheritance (HP:0010982) | 1.60926549 |
137 | Abnormality of the 4th metacarpal (HP:0010012) | 1.60682901 |
138 | Frequent falls (HP:0002359) | 1.59507761 |
139 | Increased connective tissue (HP:0009025) | 1.58803358 |
140 | Visceral angiomatosis (HP:0100761) | 1.58203421 |
141 | Increased nuchal translucency (HP:0010880) | 1.57868898 |
142 | Polycythemia (HP:0001901) | 1.57817819 |
143 | Esophageal varix (HP:0002040) | 1.57659245 |
144 | Severe short stature (HP:0003510) | 1.55067239 |
145 | Gastrointestinal carcinoma (HP:0002672) | 1.54760485 |
146 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.54760485 |
147 | Increased cerebral lipofuscin (HP:0011813) | 1.54702215 |
148 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.54612399 |
149 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.54612399 |
150 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.54612399 |
151 | Blue sclerae (HP:0000592) | 1.54115734 |
152 | Osteolytic defects of the hand bones (HP:0009699) | 1.53587999 |
153 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.53587999 |
154 | Hemangiomatosis (HP:0007461) | 1.52563686 |
155 | Camptodactyly of toe (HP:0001836) | 1.52506463 |
156 | Short 4th metacarpal (HP:0010044) | 1.52347217 |
157 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.52347217 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TRIB3 | 5.32271590 |
2 | PKN2 | 4.23486035 |
3 | EEF2K | 3.36523150 |
4 | ERN1 | 2.66000467 |
5 | MAP3K10 | 2.63635298 |
6 | PTK6 | 2.53791012 |
7 | SMG1 | 2.52280835 |
8 | PRPF4B | 2.45200528 |
9 | RIPK1 | 2.42241951 |
10 | PDGFRA | 2.13183794 |
11 | SIK1 | 1.97666350 |
12 | IRAK3 | 1.96775106 |
13 | TTN | 1.96527976 |
14 | SCYL2 | 1.96205957 |
15 | LRRK2 | 1.74030740 |
16 | CDK12 | 1.73187634 |
17 | MST1R | 1.67919758 |
18 | ICK | 1.65527701 |
19 | ALK | 1.55868109 |
20 | FGFR4 | 1.55431481 |
21 | NME2 | 1.51228572 |
22 | DDR2 | 1.50431773 |
23 | TYRO3 | 1.49378933 |
24 | TESK2 | 1.48840027 |
25 | KSR2 | 1.40837583 |
26 | CAMKK1 | 1.39061544 |
27 | PAK4 | 1.38858704 |
28 | PRKD3 | 1.38738289 |
29 | BMX | 1.37465462 |
30 | PRKD2 | 1.36339097 |
31 | LATS1 | 1.31749666 |
32 | RET | 1.30369119 |
33 | MAP3K13 | 1.27228096 |
34 | NEK1 | 1.25724602 |
35 | ARAF | 1.22438702 |
36 | CDK6 | 1.21777985 |
37 | CAMK1D | 1.21326508 |
38 | MAP3K3 | 1.19827045 |
39 | MAP3K9 | 1.19443674 |
40 | NEK2 | 1.19309343 |
41 | MTOR | 1.16495553 |
42 | STK3 | 1.14831326 |
43 | FLT3 | 1.13725043 |
44 | STK10 | 1.12298101 |
45 | CAMK1G | 1.10775280 |
46 | PTK2 | 1.09886848 |
47 | MARK2 | 1.09806275 |
48 | LATS2 | 0.99356266 |
49 | MAP3K6 | 0.98742256 |
50 | PAK2 | 0.98015052 |
51 | LMTK2 | 0.95516015 |
52 | TAOK2 | 0.93649404 |
53 | PIM2 | 0.93528469 |
54 | MAP2K3 | 0.93188945 |
55 | EPHB1 | 0.89919848 |
56 | LIMK1 | 0.88798477 |
57 | FGFR3 | 0.88729540 |
58 | MOS | 0.82683181 |
59 | MAP3K7 | 0.82390764 |
60 | TESK1 | 0.80757865 |
61 | MAP3K11 | 0.80432404 |
62 | PAK6 | 0.79721762 |
63 | DYRK1B | 0.79336476 |
64 | MAP3K2 | 0.78977999 |
65 | NEK9 | 0.77984701 |
66 | PDGFRB | 0.77669392 |
67 | JAK1 | 0.77576819 |
68 | MAP3K8 | 0.77275371 |
69 | PRKCH | 0.76743270 |
70 | GRK6 | 0.76093730 |
71 | FGFR1 | 0.74203799 |
72 | FGFR2 | 0.73172096 |
73 | NTRK1 | 0.72361042 |
74 | PASK | 0.71331687 |
75 | JAK2 | 0.70537372 |
76 | TAOK1 | 0.70220256 |
77 | FER | 0.69171768 |
78 | CDK4 | 0.65074941 |
79 | TAOK3 | 0.63962557 |
80 | JAK3 | 0.62898629 |
81 | STK38 | 0.61008895 |
82 | TYK2 | 0.60588104 |
83 | TGFBR2 | 0.58888897 |
84 | SIK2 | 0.58166553 |
85 | EPHA2 | 0.56089310 |
86 | RPS6KL1 | 0.55927638 |
87 | RPS6KC1 | 0.55927638 |
88 | RPS6KB2 | 0.55577829 |
89 | MAP2K2 | 0.54692913 |
90 | PDK3 | 0.54199146 |
91 | PDK4 | 0.54199146 |
92 | MAPK7 | 0.53145659 |
93 | MAPK15 | 0.52642516 |
94 | SIK3 | 0.52041973 |
95 | KSR1 | 0.51745402 |
96 | DAPK2 | 0.50738813 |
97 | TBK1 | 0.49398669 |
98 | FRK | 0.48412498 |
99 | MAP4K1 | 0.48210028 |
100 | EPHB2 | 0.47749937 |
101 | SGK3 | 0.47500889 |
102 | MAP3K14 | 0.47180811 |
103 | DMPK | 0.47036124 |
104 | PRKG2 | 0.46924789 |
105 | PDK1 | 0.45938223 |
106 | PAK3 | 0.45095083 |
107 | CSF1R | 0.44743259 |
108 | MAP2K1 | 0.44334961 |
109 | BLK | 0.44100415 |
110 | MAPKAPK3 | 0.44007399 |
111 | ZAP70 | 0.43841744 |
112 | BCKDK | 0.41178954 |
113 | RPS6KA2 | 0.40207506 |
114 | PRKD1 | 0.40161914 |
115 | MATK | 0.39778114 |
116 | ERBB2 | 0.39503951 |
117 | TNK2 | 0.39180749 |
118 | PDPK1 | 0.38905372 |
119 | IRAK2 | 0.38520202 |
120 | ERBB4 | 0.38434299 |
121 | MAPK12 | 0.38029750 |
122 | TTK | 0.36707145 |
123 | ROCK2 | 0.36382948 |
124 | ILK | 0.36342086 |
125 | PRKAA1 | 0.35801936 |
126 | CDC42BPA | 0.35669146 |
127 | RPS6KA6 | 0.34334781 |
128 | MAPK11 | 0.34180046 |
129 | CDK7 | 0.33397170 |
130 | MAP3K1 | 0.32979556 |
131 | MET | 0.32949264 |
132 | CSK | 0.32789387 |
133 | GSK3A | 0.32512908 |
134 | RPS6KA1 | 0.32293682 |
135 | HIPK2 | 0.32033723 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Other glycan degradation_Homo sapiens_hsa00511 | 3.96644873 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.56956909 |
3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.54095849 |
4 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.25821937 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.91037784 |
6 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.71411355 |
7 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.64082136 |
8 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.56060605 |
9 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.55906898 |
10 | Lysine degradation_Homo sapiens_hsa00310 | 1.55785924 |
11 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.55417971 |
12 | Galactose metabolism_Homo sapiens_hsa00052 | 1.54703088 |
13 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.53542130 |
14 | Prion diseases_Homo sapiens_hsa05020 | 1.52880300 |
15 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.52573998 |
16 | Bile secretion_Homo sapiens_hsa04976 | 1.49444771 |
17 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.37606699 |
18 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.32771890 |
19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.26969475 |
20 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.25515013 |
21 | Insulin resistance_Homo sapiens_hsa04931 | 1.25077373 |
22 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.22819962 |
23 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.22357656 |
24 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.20194324 |
25 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.19171229 |
26 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.15558440 |
27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.12264934 |
28 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.11724872 |
29 | Focal adhesion_Homo sapiens_hsa04510 | 1.11671962 |
30 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.11205563 |
31 | Endometrial cancer_Homo sapiens_hsa05213 | 1.10305312 |
32 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.10274346 |
33 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.10013450 |
34 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.09176838 |
35 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.08110416 |
36 | * Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.07830696 |
37 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.05762228 |
38 | Glioma_Homo sapiens_hsa05214 | 1.04599954 |
39 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.04330815 |
40 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.03932608 |
41 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.03884285 |
42 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.03104177 |
43 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.02491999 |
44 | Bladder cancer_Homo sapiens_hsa05219 | 1.00864723 |
45 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.00390787 |
46 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.97400941 |
47 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.96629911 |
48 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.96453771 |
49 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.95327381 |
50 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.92927686 |
51 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.92867152 |
52 | Thyroid cancer_Homo sapiens_hsa05216 | 0.91429233 |
53 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.91363860 |
54 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.90787482 |
55 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.90759284 |
56 | Hepatitis C_Homo sapiens_hsa05160 | 0.90454702 |
57 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.89204567 |
58 | * N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.86902024 |
59 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.86233768 |
60 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.86051982 |
61 | Adherens junction_Homo sapiens_hsa04520 | 0.85509468 |
62 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.84923299 |
63 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.84276631 |
64 | Sulfur relay system_Homo sapiens_hsa04122 | 0.83074235 |
65 | Amoebiasis_Homo sapiens_hsa05146 | 0.82269273 |
66 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.81885875 |
67 | Shigellosis_Homo sapiens_hsa05131 | 0.81622403 |
68 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.81344494 |
69 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.81177267 |
70 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.80647578 |
71 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.79910417 |
72 | Carbon metabolism_Homo sapiens_hsa01200 | 0.78641839 |
73 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.77368564 |
74 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.77338424 |
75 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.77138736 |
76 | Apoptosis_Homo sapiens_hsa04210 | 0.76555038 |
77 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.76130767 |
78 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.76062218 |
79 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.74688717 |
80 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.74328855 |
81 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.74008946 |
82 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.73170638 |
83 | Colorectal cancer_Homo sapiens_hsa05210 | 0.72793216 |
84 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.72727946 |
85 | Salmonella infection_Homo sapiens_hsa05132 | 0.72712645 |
86 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.72705987 |
87 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.72382090 |
88 | Hepatitis B_Homo sapiens_hsa05161 | 0.72364478 |
89 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.71890787 |
90 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.71429465 |
91 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.70075496 |
92 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.70057632 |
93 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.69920988 |
94 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.69690418 |
95 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.69322899 |
96 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.68452169 |
97 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.67372091 |
98 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.66914650 |
99 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.66835034 |
100 | ABC transporters_Homo sapiens_hsa02010 | 0.65444130 |
101 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.64825161 |
102 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.64262438 |
103 | Prostate cancer_Homo sapiens_hsa05215 | 0.62541204 |
104 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.61508938 |
105 | Pertussis_Homo sapiens_hsa05133 | 0.59609102 |
106 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.59213146 |
107 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.59207385 |
108 | Platelet activation_Homo sapiens_hsa04611 | 0.58932465 |
109 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.58503939 |
110 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.58010309 |
111 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.57727897 |
112 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.57553331 |
113 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.57293775 |
114 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.56956174 |
115 | Lysosome_Homo sapiens_hsa04142 | 0.56937143 |
116 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.56828971 |
117 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.55981152 |
118 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.55276814 |
119 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.55073329 |
120 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.54175453 |
121 | Endocytosis_Homo sapiens_hsa04144 | 0.53911452 |
122 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.53833748 |
123 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.53266621 |
124 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.53170283 |
125 | Axon guidance_Homo sapiens_hsa04360 | 0.52539264 |
126 | Phagosome_Homo sapiens_hsa04145 | 0.51025810 |
127 | Pathways in cancer_Homo sapiens_hsa05200 | 0.50189817 |
128 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.48599269 |
129 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.47606356 |
130 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.47001362 |
131 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.46980358 |
132 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.46631767 |
133 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.46446973 |
134 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.46305572 |
135 | Malaria_Homo sapiens_hsa05144 | 0.45911540 |
136 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.44889624 |
137 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.44721232 |
138 | Influenza A_Homo sapiens_hsa05164 | 0.44004742 |
139 | HTLV-I infection_Homo sapiens_hsa05166 | 0.43713076 |